What is ZVRA's current stock price?

ZVRA is currently trading at $10.19 with a daily change of -2.16%. Visit StocksRunner for live updates.

What are ZVRA stock's key strengths?

ZVRA current strengths include: Earnings are forecast to grow. These are updated in real time by the StocksRunner IQ algorithm.

What are the risks associated with ZVRA stock?

Current risk factors for ZVRA include: Low. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is ZVRA's current StocksRunner IQ Score?

ZVRA current StocksRunner IQ Score is: Strong Buy. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence ZVRA's StocksRunner IQ Score?

ZVRA StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ZVRA Stock Analysis & IQ Rating | Zevra Therapeutics

Q: Should I buy ZVRA stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for ZVRA aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Strong Buy. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for ZVRA?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in ZVRA near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

ZVRA

Zevra Therapeutics

$10.19

-$0.22 | -2.16%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$13.16

MKT CAP

$597.98M

52W Low

$6.19

VOL

$1.31M

P/E Ratio

7.52

AVG VOL

$1.20M

RSI

63.22

TREND

Uptrend

ZVRA Stock IQ

Login to see Zevra Therapeutics (ZVRA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ZVRA Target Price

Login to display

Strengths

ZVRA Rewards

Earnings are forecast to grow

ZVRA Price Performance

$8.4 (+21.31%)

$8.17 (+24.72%)

$11.38 (-10.46%)

$7.96 (+28.02%)

1year

6month

3month

1month

ZVRA Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

ZVRA Analysts opinion is negative and it remained unchanged from the past 3 months

ZVRA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

100%

Consensus Rating

NA

Buy
Opinion

100%

Trend
Score

100%

Potential
Score

ZVRA Street Sentiment is extremely bullish and have positive views on the near-term outlook

ZVRA Risk Level

ZVRA has Low risk level

Low

LOW

HIGH

ZVRA Performance Sentiment

Sentiments overview associated with events and the stock performance

100%

Positive

8 out of 8
events present

0%

Negative

0 out of 8
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$8.40

Resistance Price

$11.06

Current Price Range

$10.41

$8.40

$11.06

Show methods +

ZVRA Latest Analysis +

Why Zevra Therapeutics Stock Zoomed 21% Higher Today. Key PointsIt also posted 44% net revenue growth for the period.

Tue Mar 10, 2026

$11.06 | +21.27%

Potential

Noteworthy Tuesday Option Activity: ZVRA CHDN GEV. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Zevra Therapeutics Inc (Symbol: ZVRA) where a total volume of 13148 contracts has been traded thus far today a contract volume which is representative of app

Tue Mar 10, 2026

$11.06 | +21.27%

Momentum

Zevra Therapeutics Stock Gains 19% Over Partnership With GeneDx For New Genetic Testing Program . (RTTNews) - Stock of Zevra Therapeutics Inc. (ZVRA) is climbing roughly 19 percent on Tuesday morning trading after GeneDx announced a new genetic testing program with Zevra to expand access to exome sequencing to help clinicians confirm diagnosis and guide clinical decision-mak

Tue Mar 10, 2026

$11.06 | +21.27%

Momentum

Nio Zevra Therapeutics Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday. United States stocks were higher with the Dow Jones index gaining around 200 points on Tuesday.Shares of NIO Inc. (NYSE:NIO) rose sharply during Tuesday'.s session as the company reported better-than-expected fourth-quarter financial results and stronger-than-expected first-quarter revenue outlook.The company reported quarterly revenue of 34.65 billion yuan ($4.95 billion) up 75.9% year over year and

Tue Mar 10, 2026

$11.06 | +21.27%

Momentum

Zevra Therapeutics Inc. GAAP EPS of $0.19 beats by $0.14 revenue of $34.1M beats by $6.05M.

Mon Mar 9, 2026

$9.12 | +1.56%

Earnings

Zevra Therapeutics appoints Justin Renz as CFO.

Thu Mar 5, 2026

$8.79 | -1.57%

Activity

Zevra Therapeutics Appoints Justin Renz As CFO . (RTTNews) - Zevra Therapeutics Inc. (ZVRA) announced Thursday the appointment of Justin Renz as Chief Financial Officer effective March 9 2026.

Thu Mar 5, 2026

$8.79 | -1.57%

Activity

Zevra Therapeutics to Present at the Citizens Life Sciences Conference. CELEBRATION Fla. Feb. 25 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics Inc. (NasdaqGS: ZVRA) (Zevra or the Company) a commercial-stage company focused on providing therapies for people living with rare disease today announced that members of Zevras executive leadership team will present at the Citizens Life Sciences Conference in Miami Beach FL on Wednesday March 11 2026 at 9:00 a.m. ET.

Wed Feb 25, 2026

$8.93 | -0.45%

Activity

FAQ About ZVRA Stock Insights

What is ZVRA current stock price?

What are ZVRA stock strengths?

What is ZVRA Risk Level?

What is ZVRA market cap and volume?

What is ZVRA current Stock IQ?

Should I buy ZVRA stock right now?

Is ZVRA a Strong Buy right now?

What does a 'Strong Buy' rating mean for ZVRA?

What does a 'Strong Sell' rating mean for ZVRA?

What factors influence ZVRA's Stock IQ?

Explore our ZVRA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ZVRA Stock Strategies
Effective Risk Management

FIND US ON

Receive our ZVRA Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ZVRA

Zevra Therapeutics

Set Alerts

Current Price

$10.19

-$0.22 | -2.16%

52W High

$13.16

MKT CAP

$597.98M

52W Low

$6.19

VOL

$1.31M

P/E Ratio

7.52

AVG VOL

$1.20M

RSI

63.22

TREND

Uptrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

ZVRA Price Performance

$8.4 (+21.31%)

$8.17 (+24.72%)

$11.38 (-10.46%)

$7.96 (+28.02%)

1year

6month

3month

1month

ZVRA Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

ZVRA Analysts opinion is negative and it remained unchanged from the past 3 months